,Year,Title,Altmetric
0,2021,Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT).. American Journal of Hypertension. 2021  10.1093/ajh/hpab145,
1,2020,"History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial  2020  10.1002/oby.22676",
2,2019,Serum Sodium and Pulse Pressure in SPRINT. American Journal of Hypertension. 32:649-656.  2019  10.1093/ajh/hpz055,
3,2019,Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT  2019  10.1161/JAHA.118.011706,
4,2018,Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CREST. Circulation: Cardiovascular Quality and Outcomes. 11:e004663.  2018  10.1161/CIRCOUTCOMES.117.004663,
5,2018,Drugs don’t work in patients who don’t take them. Journal of Clinical Hypertension. 20:1504-1506.  2018  10.1111/jch.13380,
6,2018,"Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: Reasons for geographic and racial differences in stroke study  2018  10.5664/jcsm.7320",
7,2018,N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study. BMC Cardiovascular Disorders. 18.  2018  10.1186/s12872-018-0806-4,
8,2018,Long-term effects of an intensive lifestyle intervention on electrocardiographic criteria for left ventricular hypertrophy: The look AHEAD trial. American Journal of Hypertension. 31:541-548.  2018  10.1093/ajh/hpy004,
9,2018,"Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrial. Journal of Hypertension. 36:904-915.  2018  10.1097/HJH.0000000000001619",
10,2018,Serum Tumor Necrosis Factor-alpha associates with Myocardial Oxygen Demand and Exercise Tolerance in Postmenopausal Women.. International Journal of Exercise Science. 11:42-54.  2018,
11,2017,The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial. Journal of Bone and Mineral Research. 32:2278-2287.  2017  10.1002/jbmr.3214,
12,2017,The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). Journal of Clinical Hypertension. 19:1152-1161.  2017  10.1111/jch.13062,
13,2017,Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries. JAMA Cardiology. 2:890-895.  2017  10.1001/jamacardio.2017.0911,
14,2017,Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study  2017  10.1161/JAHA.116.004966,
15,2016,Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. Journal of the American Society of Hypertension. 10:847-856.  2016  10.1016/j.jash.2016.08.005,
16,2016,What is the association of lipid levels and incident stroke?. International Journal of Cardiology. 220:890-894.  2016  10.1016/j.ijcard.2016.06.091,
17,2016,A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. Pharmacological Research. 111:343-356.  2016  10.1016/j.phrs.2016.06.005,
18,2016,Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study. Journal of the American Society of Hypertension. 10:702-713.e4.  2016  10.1016/j.jash.2016.06.033,
19,2016,"Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study. Journal of the American Society of Hypertension. 10:625-632.e1.  2016  10.1016/j.jash.2016.05.012",
20,2016,Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study. Journal of the American Society of Hypertension. 10:578-586.e5.  2016  10.1016/j.jash.2016.05.007,
21,2016,Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT). Journal of Hypertension. 34:1224-1231.  2016  10.1097/HJH.0000000000000911,
22,2016,Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older Adults. Cardiovascular Drugs and Therapy. 30:323-331.  2016  10.1007/s10557-016-6653-6,
23,2016,Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial. Clinical Trials. 13:319-330.  2016  10.1177/1740774516631735,
24,2016,Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American women  2016  10.1139/apnm-2015-0512,
25,2016,Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Annals of Pharmacotherapy. 50:253-261.  2016  10.1177/1060028015625284,
26,2016,Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. Pharmacological Research. 103:236-252.  2016  10.1016/j.phrs.2015.12.001,
27,2015,Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011. Journal of the American College of Cardiology. 66:1864-1872.  2015  10.1016/j.jacc.2015.08.042,
28,2015,Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis. 242:87-96.  2015  10.1016/j.atherosclerosis.2015.06.056,
29,2015,Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial. Diabetologia. 58:1803-1813.  2015  10.1007/s00125-015-3610-z,
30,2015,Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials. Pharmacological Research. 99:329-336.  2015  10.1016/j.phrs.2015.07.008,
31,2015,Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study. Annals of Behavioral Medicine. 49:802-808.  2015  10.1007/s12160-015-9715-2,
32,2015,Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?. Hypertension. 65:991-992.  2015  10.1161/HYPERTENSIONAHA.115.05035,
33,2015,Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. The Clinical Neuropsychologist. 29:466-486.  2015  10.1080/13854046.2015.1042524,
34,2015,"Is pulse pressure an independent risk factor for incident stroke, REasons for geographic and racial differences in stroke. American Journal of Hypertension. 28:987-994.  2015  10.1093/ajh/hpu265",
35,2015,Systolic blood pressure control among individuals with type 2 diabetes: A comparative effectiveness analysis of three interventions. American Journal of Hypertension. 28:995-1009.  2015  10.1093/ajh/hpu292,
36,2015,Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial. Journal of the Academy of Nutrition and Dietetics. 115:731-742.  2015  10.1016/j.jand.2014.11.003,
37,2015,Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke study. American Journal of Preventive Medicine. 48:520-527.  2015  10.1016/j.amepre.2014.10.025,
38,2015,Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Current Hypertension Reports. 17.  2015  10.1007/s11906-015-0541-5,
39,2015,Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD study  2015  10.1002/oby.21005,
40,2015,Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials. Mayo Clinic Proceedings. 90:24-34.  2015  10.1016/j.mayocp.2014.08.021,
41,2014,Implications of Look AHEAD for clinical trials and clinical practice  2014  10.1111/dom.12318,
42,2014,"Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease. International Journal of Cardiology. 174:436-439.  2014  10.1016/j.ijcard.2014.04.027",
43,2014,Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke). Journal of the American College of Cardiology. 63:1626-1633.  2014  10.1016/j.jacc.2013.12.042,
44,2014,Impact of weight loss on ankle-brachial index and interartery blood pressures  2014  10.1002/oby.20658,
45,2014,"Arterial elasticity, strength, fatigue, and endurance in older women. BioMed Research International. 2014.  2014  10.1155/2014/501754",
46,2014,Prehypertension and incident acute coronary heart disease in the reasons for geographic and racial differences in stroke (Regards) study. American Journal of Hypertension. 27:245-251.  2014  10.1093/ajh/hpt200,
47,2014,Aspirin as Primary Prevention of Acute Coronary Heart Disease Events.. British Journal of Medicine and Medical Research. 4:5357-5367.  2014  10.9734/BJMMR/2014/11212,
48,2014,Cognitive effects of statin medications. CNS Drugs. 28:411-419.  2014  10.1007/s40263-014-0147-5,
49,2014,Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes. Annals of Epidemiology. 24:581-587.  2014  10.1016/j.annepidem.2014.05.007,
50,2014,Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes and Endocrinology. 2:801-809.  2014  10.1016/S2213-8587(14)70156-1,
51,2014,Hemodynamic and echocardiographic profiles in african american compared with white offspring of hypertensive parents: The HyperGEN study. American Journal of Hypertension. 27:21-26.  2014  10.1093/ajh/hpt178,
52,2014,Is pulse pressure an independent risk factor for incident acute coronary heart disease events? the REGARDS study. American Journal of Hypertension. 27:555-563.  2014  10.1093/ajh/hpt168,
53,2014,"Objective sleep, a novel risk factor for alterations in kidney function: The CARDIA study. Sleep Medicine. 15:1140-1146.  2014  10.1016/j.sleep.2014.05.021",
54,2014,Statin underuse and low prevalence of LDL-C control among U.S. Adults at high risk of coronary heart disease. American Journal of the Medical Sciences. 348:108-114.  2014  10.1097/MAJ.0000000000000292,
55,2013,Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study  2013  10.1161/JAHA.113.000447,
56,2013,Longitudinal associations between objective sleep and lipids: The CARDIA study. SLEEP. 36:1587-1595.  2013  10.5665/sleep.3104,
57,2013,"Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes. Diabetes Care. 36:2734-2740.  2013  10.2337/dc12-2318",
58,2013,Longitudinal determinants of left ventricular mass and geometry: The coronary artery risk development in young adults (CARDIA) study. Circulation: Cardiovascular Imaging. 6:769-775.  2013  10.1161/CIRCIMAGING.112.000450,
59,2013,"Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010. American Journal of Cardiology. 112:664-670.  2013  10.1016/j.amjcard.2013.04.041",
60,2013,Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational study. BMC Health Services Research. 13.  2013  10.1186/1472-6963-13-162,
61,2013,Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trial. Diabetes Care. 36:1297-1303.  2013  10.2337/dc12-0712,
62,2013,Associations between arterial elasticity and markers of inflammation in healthy older women  2013  10.1093/gerona/gls188,
63,2013,Changes in Vascular Hemodynamics in Older Women Following 16 Weeks of Combined Aerobic and Resistance Training. Journal of Clinical Hypertension. 15:241-246.  2013  10.1111/jch.12050,
64,2013,Assessment tools for unrecognized myocardial infarction: A cross-sectional analysis of the REasons for geographic and racial differences in stroke population. BMC Cardiovascular Disorders. 13.  2013  10.1186/1471-2261-13-23,
65,2013,Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke study. Journal of Stroke and Cerebrovascular Diseases. 22:500-507.  2013  10.1016/j.jstrokecerebrovasdis.2013.03.004,
66,2012,Association of race and sex with risk of incident acute coronary heart disease events  2012  10.1001/jama.2012.14306,
67,2012,Effects of antihypertensive drugs on arterial stiffness. Cardiology in Review. 20:259-263.  2012  10.1097/CRD.0b013e31825d0a44,
68,2012,Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. American Journal of Hypertension. 25:789-796.  2012  10.1038/ajh.2012.48,
69,2012,Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals. International Journal of Obesity. 36:977-981.  2012  10.1038/ijo.2011.207,
70,2012,Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients. Journal of the American Society of Hypertension. 6:66-72.  2012  10.1016/j.jash.2011.09.001,
71,2012,"Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.. American Journal of Cardiovascular Disease. 2:309-317.  2012",
72,2011,A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids in Health and Disease. 10.  2011  10.1186/1476-511X-10-237,
73,2011,"High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): An interventional study. Lipids in Health and Disease. 10.  2011  10.1186/1476-511X-10-181",
74,2011,Four-year weight losses in the look AHEAD study: Factors associated with long-term success  2011  10.1038/oby.2011.230,
75,2011,"Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS. Lipids in Health and Disease. 10.  2011  10.1186/1476-511X-10-143",
76,2011,Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial. Circulation. 123:2571-2578.  2011  10.1161/CIRCULATIONAHA.110.008250,
77,2011,The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging Biomarkers. Current Cardiovascular Risk Reports. 5:187-195.  2011  10.1007/s12170-010-0151-3,
78,2011,"Prehypertension, racial prevalence and its association with risk factors: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study. American Journal of Hypertension. 24:194-199.  2011  10.1038/ajh.2010.204",
79,2011,Is randomization to placebo safe? Risk in placebo-controlled angina trials: Angina risk meta-analysis  2011  10.1159/000335522,
80,2010,Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 33:1153-1158.  2010  10.2337/dc09-2090,
81,2010,Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study. Ethnicity and Disease. 20:282-289.  2010,
82,2010,The association of statin use and statin type and cognitive performance: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) study  2010  10.1002/clc.20758,
83,2010,Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.. SRX pharmacology. 2010:485146.  2010  10.3814/2010/485146,
84,2009,Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?. Hypertension. 54:954-955.  2009  10.1161/HYPERTENSIONAHA.109.138545,
85,2009,TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate.  2009  10.1186/1758-5996-1-16,
86,2009,"Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis. 203:633-639.  2009  10.1016/j.atherosclerosis.2008.08.005",
87,2009,Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases. Expert Opinion on Pharmacotherapy. 10:485-491.  2009  10.1517/14656560802694739,
88,2008,Weight loss treatment influences untreated spouses and the home environment: Evidence of a ripple effect. International Journal of Obesity. 32:1678-1684.  2008  10.1038/ijo.2008.150,
89,2008,Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?. Preventive Medicine. 47:161-166.  2008  10.1016/j.ypmed.2008.05.009,
90,2008,The risks associated with short-term placebo-controlled antihypertensive clinical trials: A descriptive meta-analysis. Journal of Human Hypertension. 22:659-668.  2008  10.1038/jhh.2008.51,
91,2008,Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA Study. Journal of the American Society of Hypertension. 2:70-79.  2008  10.1016/j.jash.2007.10.002,
92,2008,"Vascular stiffness and the ""chicken-or-the-egg"" question. Hypertension. 51:177-178.  2008  10.1161/HYPERTENSIONAHA.107.098830",
93,2008,Analysis of US food and drug administration warning letters: False promotional claims relating to prescription and over-the-counter medications. Pharmaceutical Medicine. 22:119-125.  2008  10.1007/BF03256691,
94,2008,Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology. 30:20-25.  2008  10.1097/MPH.0b013e318159a593,
95,2008,Measurement characteristics of the ankle-brachial index: Results from the action for health in diabetes study  2008  10.1177/1358863X08091338,
96,2007,"Importance and challenges of studying marketed drugs: What is a phase IV study? common clinical research designs, registries, and self-reporting systems. Journal of Clinical Pharmacology. 47:1074-1086.  2007  10.1177/0091270007304776",
97,2007,Diagnostic criteria and adjudication process both determine published event-rates: The ACTION trial experience. Contemporary Clinical Trials. 28:720-729.  2007  10.1016/j.cct.2007.04.001,
98,2007,Health Knowledge About Symptoms of Heart Attack and Stroke in Adult Survivors of Childhood Acute Lymphoblastic Leukemia. Annals of Epidemiology. 17:778-781.  2007  10.1016/j.annepidem.2007.05.004,
99,2006,Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diabetes and Vascular Disease Research. 3:202-215.  2006  10.3132/dvdr.2006.031,
100,2006,Consent for genetics studies among clinical trial participants: Findings from action for health in diabetes (Look AHEAD). Clinical Trials. 3:443-456.  2006  10.1177/1740774506070727,
101,2006,Clinical trial design issues: At least 10 things you should look for in clinical trials. Journal of Clinical Pharmacology. 46:1106-1115.  2006  10.1177/0091270006290336,
102,2006,Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 107:1303-1312.  2006  10.1002/cncr.22120,
103,2006,Antihypertensive safety and efficacy and physicians and patient satisfaction: Results from a phase 4 practice-based clinical experience trial with diltiazem LA. Advances in Therapy. 23:284-294.  2006  10.1007/BF02850134,
104,2006,Pharmacogenetics of antihypertensive treatment. Vascular Pharmacology. 44:107-118.  2006  10.1016/j.vph.2005.09.010,
105,2006,Cardiovascular events in hypertension trials: A focus on perindopril. Cardiology in Review. 23:44-45.  2006,
106,2005,Is HDL cholesterol an independent cardiovascular disease risk factor?. Cardiology in Review. 22:42-43.  2005,
107,2005,The obesity epidemic: New therapeutic approaches. Cardiology in Review. 22:42-43.  2005,
108,2005,Part 3: Overview of study designs. Cardiology in Review. 22:44-45.  2005,
109,2005,Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris. Expert Opinion on Pharmacotherapy. 6:765-776.  2005  10.1517/14656566.6.5.765,
110,2005,Essential characteristics of clinical research and strength of evidence. Cardiology in Review. 22:41-43.  2005,
111,2005,Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris. American Heart Journal. 149:e1.  2005  10.1016/j.ahj.2004.08.002,
112,2004,"Clinical research: Definitions, ""anatomy and physiology,"" and universal truth. Cardiology in Review. 21:44-47.  2004",
113,2004,"Polypharmacy - The good, the bad, and the ugly. Cardiology in Review. 21:34.  2004",
114,2004,Determinants of radial artery pulse wave analysis in asymptomatic individuals. American Journal of Hypertension. 17:647-653.  2004  10.1016/j.amjhyper.2004.03.671,
115,2003,Revisiting erectile dysfunction in cardiovascular patients. Cardiology in Review. 20:42-43.  2003,
116,2003,Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. American Journal of Hypertension. 16:265-269.  2003  10.1016/S0895-7061(02)03271-5,
117,2003,Diltiazem Hydrochloride: New Technologies and Evolution of Diltiazem  2003  10.1002/clc.4960261605,
118,2003,Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. American Journal of Hypertension. 16:51-58.  2003  10.1016/S0895-7061(02)03153-9,
119,2002,"The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. Journal of the American College of Cardiology. 40:2006-2012.  2002  10.1016/S0735-1097(02)02563-9",
120,2002,Hypertension syndrome and cardiovascular events. Sendrom -Istanbul-. 14:38-46.  2002,
121,2002,Effect of doxazosin on arterial elasticity: Functional versus structural changes. Journal of Clinical Pharmacology. 42:1105-1108.  2002  10.1177/009127002401382704,
122,2002,"Extended-release fluvastatin 80 mg shows greater efficacy, with comparable tolerability, versus immediate-release fluvastatin 40 mg for once daily treatment of primary hypercholesterolaemia. British Journal of Cardiology. 9:469-475.  2002",
123,2002,Safety of PDE 5 inhibition in patients with cardiovascular disease. Cardiology in Review. 19:32-33.  2002,
124,2002,SERMs revisited. Cardiology in Review. 19:42.  2002,
125,2001,Arterial compliance abnormalities in isolated systolic hypertension. American Journal of Hypertension. 14:1007-1011.  2001  10.1016/S0895-7061(01)02160-4,
126,2001,"Low-density lipoprotein size, pravastatin treatment, and coronary events  2001  10.1001/jama.286.12.1468",
127,2001,Blood pressure and arterial compliance in young adults: The Minnesota Children's Blood Pressure Study. American Journal of Hypertension. 14:200-205.  2001  10.1016/S0895-7061(00)01262-0,
128,2001,Hypertension syndrome and cardiovascular events: High blood pressure is only one risk factor. Postgraduate Medicine. 110:29-36.  2001  10.1080/00325481.2001.11445493,
129,2001,Safety of combination therapy for treatment of dyslipidemia. Cardiology in Review. 18:37-38.  2001,
130,2001,"Treating hypertension in the elderly - Whom to treat, when, and with what?. Journal of Clinical Hypertension. 3:103-109.  2001  10.1111/j.1524-6175.2001.00446.x",
131,2000,Will angiotensin receptor blockers play a role in heart failure treatment?. Cardiology in Review. 17:36-37.  2000,
132,2000,"On Arterial Physiology, Pathophysiology of Vascular Compliance, and Cardiovascular Disease  2000",
133,2000,Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy?. Current Hypertension Reports. 2:392-397.  2000  10.1007/s11906-000-0043-x,
134,2000,Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia  2000  10.1002/clc.4960230711,
135,1999,Circadian Variations and Chronotherapeutic Implications for Cardiovascular Management: A Focus on COER Verapamil  1999,
136,1999,New physiologic therapy for diabetes. Cardiology in Review. 16:10.  1999,
137,1999,Prospects for therapy of nitrate tolerance  1999  10.1016/S0140-6736(98)00373-0,
138,1999,Anti-ischemic effects of Amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. American Journal of Cardiology. 83:1117-1119.  1999  10.1016/S0002-9149(99)00024-7,
139,1999,"Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. American Journal of Cardiology. 83:507-514.  1999  10.1016/S0002-9149(98)00904-7",
140,1999,Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance. Hypertension. 33:1392-1398.  1999  10.1161/01.HYP.33.6.1392,
141,1998,Hormone replacement therapy: Should it be routine?. Cardiology in Review. 15:19-20.  1998,
142,1998,Clinical trials of herbal supplements to begin. Cardiology in Review. 15:61.  1998,
143,1998,Sildenafil: Possible pitfalls for the heart patient. Cardiology in Review. 15:54.  1998,
144,1998,Novel approaches to heart failure. Cardiology in Review. 15:15-16.  1998,
145,1998,Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial. Annals of Internal Medicine. 129:681-689.  1998  10.7326/0003-4819-129-9-199811010-00002,
146,1998,Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial. Journal of the American College of Cardiology. 32:140-146.  1998  10.1016/S0735-1097(98)00202-2,
147,1998,Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris  1998  10.1002/clc.4960210707,
148,1998,Chronotherapeutics in cardiovascular disease. Blood Pressure Monitoring. 3:53-57.  1998,
149,1998,Estrogen/progestin therapy: Putting the HERS results in context. Cardiology in Review. 15:55.  1998,
150,1998,"Hypertension, hypertrophy, hormones, and the heart. American Heart Journal. 135.  1998  10.1053/hj.1998.v135.86973",
151,1998,Single-pill combination therapy. Cardiology in Review. 15:8.  1998,
152,1998,The importance of arterial compliance in cardiovascular drug therapy. Journal of Clinical Pharmacology. 38:202-212.  1998  10.1002/j.1552-4604.1998.tb04417.x,
153,1998,The relevance of T-type calcium antagonists: A profile of mibefradil. Journal of Clinical Pharmacology. 38:659-669.  1998  10.1002/j.1552-4604.1998.tb04804.x,
154,1998,Toward the ideal target goal for lowering cholesterol. Cardiology in Review. 15:43.  1998,
155,1997,Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. American Journal of Cardiology. 80:1546-1550.  1997  10.1016/S0002-9149(97)00802-3,
156,1997,Advances in antiplatelet therapy (continued). Cardiology in Review. 14:52.  1997,
157,1997,Beta blocking agents in congestive heart failure. Cardiology in Review. 14:20-21.  1997,
158,1997,New treatment options for diabetes mellitus. Cardiology in Review. 14:17.  1997,
159,1997,Vascular compliance and cardiovascular disease: A risk factor or a marker?. American Journal of Hypertension. 10:1175-1189.  1997  10.1016/S0895-7061(97)00311-7,
160,1997,The time course of left ventricular remodeling after acute myocardial infarction. American Journal of Cardiology. 80:506-507.  1997  10.1016/S0002-9149(97)00403-7,
161,1997,"Antianginal response to once-daily diltiazem CD in patients receiving concomitant β-blockers, long-acting nitrates, or both  1997",
162,1997,"Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. American Journal of Cardiology. 79:1401-1405.  1997  10.1016/S000-2914(99)X0015-0",
163,1997,Eccentric dosage regimen for isosorbide dinitrate. American Family Physician. 55.  1997,
164,1997,Eccentric dosage regimen for isosorbide dinitrate.. American Family Physician. 55:57-58.  1997,
165,1997,"Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Journal of Clinical Pharmacology. 37:53-57.  1997  10.1177/009127009703700109",
166,1996,Chronobiology and chronotherapeutics. Cardiology in Review. 13:13-17.  1996,
167,1996,Atherosclerosis: Risk factors and the vascular endothelium. American Heart Journal. 131:379-384.  1996  10.1016/S0002-8703(96)90370-1,
168,1996,The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl. American Journal of Cardiology. 77:83-85.  1996  10.1016/S0002-9149(97)89140-0,
169,1996,The placebo effect in cardiovascular disease. American Heart Journal. 132:1207-1221.  1996  10.1016/S0002-8703(96)90465-2,
170,1995,Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris. American Journal of Cardiology. 75.  1995  10.1016/S0002-9149(99)80451-2,
171,1995,Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable Angina. Journal of Clinical Pharmacology. 35:780-784.  1995  10.1002/j.1552-4604.1995.tb04120.x,
172,1995,Reply. American Heart Journal. 129:1223-1224.  1995  10.1016/0002-8703(95)90411-5,
173,1995,The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension  1995  10.1016/0149-2918(95)80028-X,
174,1995,The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension  1995  10.1016/0149-2918(95)80003-4,
175,1994,Mononitrates: Defining the ideal long-acting nitrate  1994,
176,1994,Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. American Journal of Cardiology. 74:9-17.  1994  10.1016/0002-9149(94)90483-9,
177,1994,Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris. American Journal of Cardiology. 73:1165-1168.  1994  10.1016/0002-9149(94)90175-9,
178,1994,Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris. American Journal of Cardiology. 73:213-218.  1994  10.1016/0002-9149(94)90221-6,
179,1994,Phenomenon of nitrate tolerance. American Heart Journal. 128:137-146.  1994  10.1016/0002-8703(94)90020-5,
180,1994,The role of coronary tone and increased demand in daily ischemia [1]. Circulation. 89:2454-2455.  1994  10.1161/01.CIR.89.5.2454,
181,1994,Uniformity of captopril benefit in the SAVE study: Subgroup analysis. European Heart Journal. 15:2-8.  1994  10.1093/eurheartj/15.suppl_b.2,
182,1993,Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. American Journal of Cardiology. 72:1249-1256.  1993  10.1016/0002-9149(93)90292-K,
183,1993,Is the site of maximal coronary artery narrowing the culprit for future myocardial infarction?. American Journal of Cardiology. 72:861-862.  1993  10.1016/0002-9149(93)91089-Z,
184,1993,Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation. 88:92-100.  1993  10.1161/01.cir.88.1.92,
185,1993,"Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. Journal of the American College of Cardiology. 21:1605-1611.  1993  10.1016/0735-1097(93)90375-B",
186,1993,Endothelium-derived vasoactive substances in myocardial ischemia. Primary cardiology. 19:12-14.  1993,
187,1993,Subsets of ambulatory myocardial ischemia based on heart rate activity: Circadian distribution and response to anti-ischemic medication. Circulation. 88:92-100.  1993  10.1161/01.CIR.88.1.92,
188,1992,"Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo‐controlled, randomized double‐blind study  1992  10.1002/clc.4960150709",
189,1992,Safety And Efficacy of Metoprolol in the Treatment of Hypertension in the Elderly. Journal of the American Geriatrics Society. 40:354-358.  1992  10.1111/j.1532-5415.1992.tb02134.x,
190,1991,Clinical aspects of silent myocardial ischemia in China. American Journal of Cardiology. 67:1146-1147.  1991  10.1016/0002-9149(91)90883-M,
191,1991,"Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug Trials  1991  10.1001/jama.1991.03460120064037",
192,1991,"Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 84:2398-2408.  1991  10.1161/01.CIR.84.6.2398",
193,1991,Update on Nitrate Therapy. Journal of Clinical Pharmacology. 31:697-701.  1991  10.1002/j.1552-4604.1991.tb03762.x,
194,1990,"Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. Circulation. 82:1962-1972.  1990  10.1161/01.CIR.82.6.1962",
195,1990,Long‐Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise Tolerance. Journal of Clinical Pharmacology. 30:1106-1111.  1990  10.1002/j.1552-4604.1990.tb01853.x,
196,1990,The risk factor profile for patients with asymptomatic myocardial ischemia. Journal of applied cardiology. 5:239-244.  1990,
197,1990,Update on nitrate therapy: Reexamination of tolerance issues and efficacy endpoints of long-acting products. Hospital formulary. 25:42-49.  1990,
198,1989,"Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients. American Journal of Cardiology. 63.  1989  10.1016/0002-9149(89)90133-1",
199,1989,Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol. American Journal of Cardiology. 63.  1989  10.1016/0002-9149(89)90131-8,
200,1989,Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. Journal of the American College of Cardiology. 13:786-793.  1989  10.1016/0735-1097(89)90216-7,
201,1989,Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.. American Journal of Hypertension. 2:154-157.  1989  10.1093/ajh/2.3.154,
202,1989,Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris. American Heart Journal. 118:1127-1128.  1989  10.1016/0002-8703(89)90841-7,
203,1989,Predictors of left ventricular hypertrophy in patients with essential hypertension  1989  10.1002/clc.4960120303,
204,1989,Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients with Dilevalol and Metoprolol—A Double Blind Randomized Study. Journal of Clinical Pharmacology. 29:791-797.  1989  10.1002/j.1552-4604.1989.tb03421.x,
205,1989,Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension. American Journal of Hypertension. 2:154-157.  1989  10.1093/ajh/2.3.154,
206,1989,Silent myocardial ischemia: Improvement with nisoldipine therapy. Southern Medical Journal. 82:32-34.  1989  10.1097/00007611-198901000-00010,
207,1989,The Efficacy and Safety of Dilevalol in Patients with Chronic Stable Angina Pectoris. Journal of Clinical Pharmacology. 29:983-988.  1989  10.1002/j.1552-4604.1989.tb03265.x,
208,1989,The Impact of Antianginal Drug Therapy on Asymptomatic Myocardial Ischemia. Journal of Clinical Pharmacology. 29:722-727.  1989  10.1002/j.1552-4604.1989.tb03406.x,
209,1988,Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris. American Journal of Cardiology. 62:518-522.  1988  10.1016/0002-9149(88)90647-9,
210,1988,Clinical assessment of beta blockade  1988  10.1002/clc.4960110508,
211,1988,Dilevalol compared to metoprolol for treatment of hypertension: A multicenter trial. Journal of Cardiovascular Pharmacology. 11.  1988  10.1097/00005344-198800000-00010,
212,1988,Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction. American Journal of Cardiology. 61:21-25.  1988  10.1016/0002-9149(88)91297-0,
213,1988,Relation of results of exercise stress tests in young women to phases of the menstrual cycle. American Journal of Cardiology. 61:197-199.  1988  10.1016/0002-9149(88)91334-3,
214,1987,A paradoxical response to arrhythmia therapy  1987  10.1080/21548331.1987.11703345,
215,1986,The role of exercise testing in the identification of patients with silent myocardial ischemia. Cardiology Clinics. 4:705-715.  1986  10.1016/s0733-8651(18)30590-3,
216,1985,Management of cardiac arrhythmias  1985  10.1080/21548331.1985.11703121,
217,1984,Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension. Journal of Cardiovascular Pharmacology. 6:S1105-S1108.  1984  10.1097/00005344-198400067-00034,
218,1984,Exercise-induced S-T segment alterations.. Cardiology Clinics. 2:337-347.  1984  10.1016/s0733-8651(18)30728-8,
219,1984,Predischarge post-myocardial infarction testing: exercise electrocardiography.. Cardiology Clinics. 2:379-390.  1984  10.1016/s0733-8651(18)30733-1,
220,1984,Symposium on clinical exercise testing. Introduction and overview.. Cardiology Clinics. 2:311-317.  1984  10.1016/s0733-8651(18)30725-2,
221,1983,Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias. American Journal of Cardiology. 52:992-995.  1983  10.1016/0002-9149(83)90518-0,
222,1982,Pulmonary valve echogram. American Journal of Cardiology. 49:1085-1086.  1982  10.1016/0002-9149(82)92615-7,
223,1982,The independent impact of M-mode echocardiography on the diagnosis of suspected endocarditis. Journal of Cardiovascular Ultrasonography. 1:271-275.  1982,
224,1982,The rhythms of aging. What new do we know from Holter monitoring?. Chest. 81:266-267.  1982  10.1378/chest.81.3.266,
225,1981,An automated system for blood pressure determination during exercise. Circulation. 63:348-353.  1981  10.1161/01.CIR.63.2.348,
226,1981,Bayes' theorem in perspective: Toward improved interpretation of the exercise test. American Heart Journal. 101:116-117.  1981  10.1016/0002-8703(81)90397-5,
227,1980,"Cardiovascular and sympathetic reactions to in-flight emergency responses among base fire fighters. Aviation, Space, and Environmental Medicine. 51:788-792.  1980",
228,1980,Arrhythmias detected by ambulatory monitoring. Lack of correlation with symptoms of dizziness and syncope. Chest. 77:722-725.  1980  10.1378/chest.77.6.722,
229,1980,Chloral hydrate overdose and cardiac arrhythmias. Chest. 77:232-235.  1980  10.1378/chest.77.2.232,
230,1980,Exercise and coronary artery disease. The Journal of the Florida Medical Association. 67:373-377.  1980,
231,1979,Electrocardiogram of the month. A node of caution.  1979,
232,1979,Preanesthetic Management of the Hypertensive Patient. New England Journal of Medicine. 301:942.  1979  10.1056/NEJM197910253011712,
233,1979,Electrocardiogram of the month. The breaking point.  1979,
234,1979,Electrocardiogram of the month: run silent run deep.  1979,
235,1979,Three is company.  1979,
236,1979,Atrial fibrillatory wave size and etiology of heart disease. American Heart Journal. 98:274.  1979  10.1016/0002-8703(79)90237-0,
237,1979,Echocardiographic incidence of pericardial effusion in patients resuscitated by emergency medical technicians. JACEP. 8:6-8.  1979  10.1016/s0361-1124(79)80438-4,
238,1979,Occurrence of frequent complex arrhythmias detected by ambulatory monitoring. Findings in an apparently healthy asymptomatic elderly population. Chest. 75:565-568.  1979  10.1378/chest.75.5.565,
239,1979,When cardiac patients become surgical patients  1979  10.1080/21548331.1979.11707509,
240,1978,Heart rate response to 'fright stress'  1978,
241,1978,The electrocardiogram in patients with congenital absence of the pectoralis major muscle.  1978,
242,1978,Twenty-four hours with the happy Holter.  1978,
243,1978,"Electrocardiogram of the month: up, up and away.  1978",
244,1978,Problems of dental patients with cardiovascular disease. Rivista italiana di stomatologia. 47:64-71.  1978,
245,1978,Heartbreak or headache?  1978,
246,1978,Pulmonary valve echography: Review and update. Medical ultrasound. 2:26-32.  1978,
247,1978,Traumatic coronary artery fistula. Southern Medical Journal. 71:649-651.  1978  10.1097/00007611-197806000-00011,
248,1977,Electrocardiogram of the month. Uncommon cause for pause.  1977,
249,1977,Ventricular asynergy  1977,
250,1977,Electrocardiogram of the month: A message in massage.  1977,
251,1977,A heart matter or the gallbladder?  1977,
252,1977,The pre-excitation syndromes.  1977,
253,1977,Atrial flutter. Tracing an elusive arrhythmia. Postgraduate Medicine. 62:61-67.  1977  10.1080/00325481.1977.11714577,
254,1977,Posterior leaflet motion in mitral stenosis. Chest. 71:87-88.  1977  10.1378/chest.71.1.87,
255,1977,Pulmonary valve fluttering in subpulmonic ventricular septal defect. American Heart Journal. 94:3-5.  1977  10.1016/S0002-8703(77)80336-0,
256,1977,The arrhythmogenic effect of static electricity on the dog heart. American Heart Journal. 93:496-500.  1977  10.1016/S0002-8703(77)80412-2,
257,1977,The problems of patients with cardiovascular disease undergoing dental treatment.. Journal of the American Dental Association. 94:1158-1162.  1977  10.14219/jada.archive.1977.0386,
258,1976,Accentuate the negative - eliminate the positive.  1976,
259,1976,Right cervical aortic arch and aortic stenosis: a case report.  1976,
260,1976,What the internist should know about echocardiography.. Journal of the Mississippi State Medical Association. 17:291-294.  1976,
261,1976,Electrocardiogram of the month.  1976,
262,1976,Illustrative echocardiogram: late mitral valve opening in aortic regurgitation.. Chest. 70:70-71.  1976  10.1378/chest.70.1.70,
263,1976,Electrocardiogram of the month. Battle of the bulge.  1976,
264,1976,Late mitral valve opening in aortic regurgitation. Chest. 70:70-71.  1976  10.1378/chest.70.1.70,
265,1976,Left atrial size in patients with atrial fibrillation: an echocardiographic study. American Journal of the Medical Sciences. 272:57-64.  1976  10.1097/00000441-197607000-00007,
266,1976,Three unusual complications resulting from attempted repair of partial anomalous pulmonary venous drainage. Chest. 69:384-387.  1976  10.1378/chest.69.3.384,
267,1975,Acute rheumatic fever. J.LA.MED.SOC.. 127:61-68.  1975,
268,1975,On the QT.  1975,
269,1975,Rapid atrial stimulation for the conversion of arrhythmias.  1975,
270,1975,Bacterial Endocarditis: Occurrence on a Traumatically Ruptured Aortic Valve  1975  10.1001/jama.1975.03260070068027,
271,1975,Electrocardiogram of the month.  1975,
272,1975,Electrocardiogram of the month.  1975,
273,1975,His bundle electrogram in trifascicular disease: Report of a case studied with His bundle electrograms. Journal of Electrocardiology. 8:269-273.  1975  10.1016/S0022-0736(75)80057-4,
274,1974,Fixation of I.V. Catheters. New England Journal of Medicine. 291:1309-1310.  1974  10.1056/NEJM197412122912417,
275,1974,Electrocardiogram of the month. J.LA MED.SOC.. 126:60-61.  1974,
276,1974,Hyperactive carotid sinus reflex and his bundle electrography. Journal of Electrocardiology. 7:71-74.  1974  10.1016/S0022-0736(74)80011-7,
277,1974,Venospasm during cardiac catheterization. American Heart Journal. 88:813.  1974,
278,1974,Venospasm during cardiac catheterization. American Heart Journal. 88:811-812.  1974  10.1016/0002-8703(74)90297-X,
279,1973,Atrial injury current in pericarditis.. Archives of Internal Medicine. 131:657-662.  1973,
280,1973,Atrial Injury Current in Pericarditis. Archives of Internal Medicine. 131:657-662.  1973  10.1001/archinte.1973.00320110041005,
281,1973,Renal abnormalities discovered by routine postangiography abdominal films. American Heart Journal. 86:57-60.  1973  10.1016/0002-8703(73)90008-2,
282,1973,Synchronized versus nonsynchronized electrocardioversion  1973  10.1093/milmed/138.8.478,
283,1973,Thrombogenicity of guide wires. American Journal of Cardiology. 32:943-946.  1973  10.1016/S0002-9149(73)80162-6,
284,1972,Interpretation of intraventricular block on a trifascicular basis. Giornale Italiano di Cardiologia. 2:921-932.  1972,
285,1972,Friedreich's ataxia and myocardiopathies. American Heart Journal. 84:843.  1972  10.1016/0002-8703(72)90083-X,
286,1972,Paroxysmal atrial tachycardia: a presenting manifestation of hyperthyroidism: case report.  1972  10.1093/milmed/137.2.77,
287,1972,"Thirty-two cases of interventricular septal defect and aortic insufficiency. Clinical, hemodynamic and surgical features. American Journal of Medicine. 53:473-480.  1972  10.1016/0002-9343(72)90143-X",
288,1971,Intracavitary Electrocardiography as a Guide to Pacemaker Positioning  1971  10.1001/jama.1971.03180290059008,
289,1971,Hypertrophic obstructive cardiomyopathy and Friedreich's ataxia. American Journal of Cardiology. 28:496.  1971  10.1016/0002-9149(71)90020-8,
290,1971,Intermittent isolated left posterior fascicular block.. American Journal of the Medical Sciences. 261:155-160.  1971  10.1097/00000441-197103000-00005,
291,1971,"Left atrial myxoma. Report of a case including hemodynamic, surgical, histologic and histochemical characteristics. American Journal of Medicine. 50:113-122.  1971  10.1016/0002-9343(71)90210-5",
292,1971,Salivary gland hemorrhage as a complication of anticoagulation therapy. American Heart Journal. 82:282-283.  1971  10.1016/0002-8703(71)90282-1,
293,1970,Blood pressure in pulmonary fibrosis.. Annals of Internal Medicine. 73:341.  1970  10.7326/0003-4819-73-2-341_1,
294,1970,Hypertrophic subaortic stenosis occurring in a patient with Friedreich's ataxia.. American Journal of the Medical Sciences. 260:279-284.  1970  10.1097/00000441-197011000-00005,
295,1970,Salivary gland hemorrhage-An unusual complication of Coumadin anticoagulation. American Heart Journal. 80:675-676.  1970  10.1016/0002-8703(70)90013-X,
296,1968,Tuberculous pericarditis: is limited pericardial biopsy sufficient for diagnosis? Report of two cases.. The American review of respiratory disease. 98:287-291.  1968,
297,1968,Pituitary “Stone” An Unusual Calcification  1968  10.1001/jama.1968.03140050051017,
298,1968,Isolated massive chylopericardium. American Heart Journal. 75.  1968  10.1016/0002-8703(68)90326-8,
299,1967,The pulse rate in falciparum malaria: a clinical note.  1967  10.1093/milmed/132.3.186,
